Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and MHC-I antigen cross processing by TLR9

被引：0
|
作者：
Simmons, Daimon [1 ]
Canaday, David [1 ]
Liu, Yi [1 ]
Boom, W. Henry [1 ]
Harding, Clifford [1 ]
机构：
[1] Case Western Reserve Univ, Pathol & Infect Dis, Cleveland, OH 44106 USA
来源：
JOURNAL OF IMMUNOLOGY | 2010年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
37.15
引用
收藏
页数：1
相关论文
共 31 条
  • [21] Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)
    Babiker, Hani
    Borazenci, Erkut
    Subbiah, Vivek
    Agarwala, Sanjiv
    Algazi, Alain
    Schachter, Jacob
    Lotem, Michael
    Maurice-Dror, Corinne
    Hendler, Daniel
    Rahimian, Shah
    Minderman, Hans
    Haymaker, Cara
    Mahadevan, Daruka
    Bernatchez, Chantale
    Murthy, Ravi
    Hultsch, Rolf
    Kaplan, Nadia
    Woodhead, Gregory
    Hennemeyer, Charles
    Chunduru, Srinivas
    Anderson, Peter M.
    Diab, Adi
    Puzanov, Igor
    CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5079 - 5087
  • [22] The intestinal microbiome and Cetobacterium somerae inhibit viral infection through TLR2-type I IFN signaling axis in zebrafish
    Liang, Hui
    Li, Ming
    Chen, Jie
    Zhou, Wenhao
    Xia, Dongmei
    Ding, Qianwen
    Yang, Yalin
    Zhang, Zhen
    Ran, Chao
    Zhou, Zhigang
    MICROBIOME, 2024, 12 (01):
  • [23] Mycobacterium tuberculosis LprG (Rv1411c):: A novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing
    Gehring, AJ
    Dobos, KM
    Belisle, OT
    Harding, CV
    Boom, WH
    JOURNAL OF IMMUNOLOGY, 2004, 173 (04): : 2660 - 2668
  • [24] Rhinovirus-Induced SIRT-1 via TLR2 Regulates Subsequent Type I and Type III IFN Responses in Airway Epithelial Cells
    Xander, Nathaniel
    Vari, Hymavathi Reddy
    Eskandar, Rewees
    Li, Wuyan
    Bolla, Sudhir
    Marchetti, Nathaniel
    Sajjan, Umadevi S.
    JOURNAL OF IMMUNOLOGY, 2019, 203 (09): : 2508 - 2519
  • [25] Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-γ and IL-17 secretion by activated human PBMC
    Meyers, John A.
    Mangini, Alyson J.
    Nagai, Taro
    Roff, Calvin F.
    Sehy, David
    van Seventer, Gijs A.
    van Seventer, Jean Maguire
    CYTOKINE, 2006, 35 (5-6) : 235 - 246
  • [26] Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment
    Seki, Reiko
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [27] Recombinant Lipoprotein Rv1016c Derived from Mycobacterium tuberculosis Is a TLR-2 Ligand that Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing
    Su, Haibo
    Zhu, Shenglin
    Zhu, Lin
    Huang, Wei
    Wang, Honghai
    Zhang, Zhi
    Xu, Ying
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2016, 6
  • [28] Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway
    Saito, Masumi
    Makino, Yumi
    Inoue, Kumi
    Watanabe, Yoshino
    Hoshi, Osamu
    Kubota, Tetsuo
    IMMUNOLOGICAL MEDICINE, 2021, 44 (02) : 124 - 135
  • [29] Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation
    Gotoh, Kazuhito
    Tanaka, Yoshihiko
    Nishikimi, Akihiko
    Nakamura, Risa
    Yamada, Hisakata
    Maeda, Naoyoshi
    Ishikawa, Takahiro
    Hoshino, Katsuaki
    Uruno, Takehito
    Cao, Qinhong
    Higashi, Sadayuki
    Kawaguchi, Yasushi
    Enjoji, Munechika
    Takayanagi, Ryoichi
    Kaisho, Tsuneyasu
    Yoshikai, Yasunobu
    Fukui, Yoshinori
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (04): : 721 - 730
  • [30] IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism
    Stockinger, S
    Reutterer, B
    Schaljo, B
    Schellack, C
    Brunner, S
    Materna, T
    Yamamoto, M
    Akira, S
    Taniguchi, T
    Murray, PJ
    Müller, M
    Decker, T
    JOURNAL OF IMMUNOLOGY, 2004, 173 (12): : 7416 - 7425
1234